Edition:
United Kingdom

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

7.34USD
23 Jan 2019
Change (% chg)

-- (--)
Prev Close
$7.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
58,701
52-wk High
$8.70
52-wk Low
$3.58

Select another date:

Wed, Dec 19 2018

BRIEF-Intec Pharma - Plan To Initiate A PK Study Of AP-Cannabidiol (CBD) In First Half Of 2019

* INTEC PHARMA LTD - PLAN TO INITIATE A PK STUDY OF AP-CANNABIDIOL (CBD) IN FIRST HALF OF 2019.

Israel's Intec Pharma eyes revenue from Parkinson's drug in 2019

TEL AVIV Israel's Intec Pharma, which is conducting a late stage trial for its long-lasting pill to treat Parkinson's disease, expects to start earning money from the program sometime in 2019.

Israel's Intec Pharma eyes revenue from Parkinson's drug in 2019

TEL AVIV, Nov 7 Israel's Intec Pharma, which is conducting a late stage trial for its long-lasting pill to treat Parkinson's disease, expects to start earning money from the programme sometime in 2019.

Select another date: